SubHero Banner
Text

June 2021

Core topics in this month’s edition include:

  • Actemra (tocilizumab) - emergency use authorization approval
  • Aduhelm (aducanumab) - new drug approval
  • Chantix (varenicline) - distribution and recall update
  • Wegovy (semaglutide) - new drug approval

Download PDF